SCHEMBL13502696

SCHEMBL13502696

CC(C)(C)C1CSCCN(C(C)(C)C)C1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14170744 0.76 — —
SCHEMBL9962273 0.75 POLB (0.32) —
SCHEMBL19770241 0.72 DPP4 (0.32) —
SCHEMBL13434939 0.70 DPP4 (0.31) —
SCHEMBL10553723 0.69 NOS3 (0.32) —
SCHEMBL13502695 0.68 PIK3CD (0.33) —
SCHEMBL19449153 0.67 POLB (0.32) —
SCHEMBL10129310 0.62 INMT (0.36) —
SCHEMBL14170734 0.62 CNR1 (0.31) —
SCHEMBL17414488 0.60 LMNA (0.39) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100041639-A1 CYCLIC MALONAMIDES AS INHIBITORS OF A BETA PROTEIN PRODUCTION BRISTOL-MYERS SQIBB PHARMA COMAPNY (US) 2010-02-18 — — US disclosed
US-20090062256-A1 LACTAMS SUBSTITUTED BY CYCLIC SUCCINATES AS INHIBITORS OF Abeta PROTEIN PRODUCTION BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2009-03-05 — — US disclosed
Send feedback